Showing results (1121-1130 of 1,230) with videos related to
Sort By:
Pageof 123
Autoimmunity|July 22, 2014
Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: A five-year follow-up studyAnnamaria Erdei, Gyorgy Paragh, Peter Kovacs, et al.The Plant Journal : for Cell and Molecular Biology|April 5, 2024
Nutri-cereal tissue-specific transcriptome atlas during development: Functional integration of gene expression to identify mineral uptake pathways in little millet (Panicum sumatrense)Shankar Pahari, Neha Vaid, Raju Soolanayakanahally, et al.Cells|April 13, 2026
Correction: Janjetovic et al. Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 2024, 13, 239Zorica Janjetovic, Shariq Qayyum, Sivani B Reddy, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitroHulda R Jonsdottir, Denise Siegrist, Thomas Julien, et al.Andrologia|November 25, 2020
Safety and efficacy of traditional Chinese medicine, Qiaoshao formula, combined with dapoxetine in the treatment of premature ejaculation: An open-label, real-life, retrospective multicentre study in Chinese menJun Guo, Fu Wang, Qing Zhou, et al.JAACAP Open|September 9, 2025
Suicidal Thoughts and Behaviors in Elementary School-Aged Youth: A Pilot Study in 5- to 10-Year-OldsAdam Bryant Miller, Margaret A Sheridan, Andrea Pelletier-Baldelli, et al.Cells|February 9, 2024
Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human FibroblastsZorica Janjetovic, Shariq Qayyum, Sivani B Reddy, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 7, 2018
Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRTJudit Boda-Heggemann, Anika Jahnke, Mark K H Chan, et al.Acta Oncologica (Stockholm, Sweden)|April 5, 2023
Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysisConstantin Dreher, Gustavo R Sarria, Georgia Miebach, et al.Drugs & Aging|August 2, 2025
1-Month Versus 12-Month Dual Antiplatelet Therapy for Patients with Chronic Total Occlusion After Successful Percutaneous Coronary InterventionShuai Zhao, Boda Zhu, Yan Chen, et al.Pageof 123